Comprehensive ctDNA measurements improve prediction of clinical outcomes and enable dynamic tracking of disease progression in advanced pancreatic cancer.

Morten Lapin Karin H Edland Kjersti Tjensvoll Satu Oltedal Marie Austdal Herish Garresori Yves Rozenholc Bjørnar Gilje Oddmund Nordgård

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)

ctDNA is an independent prognostic marker that can be used to detect treatment failure and disease progression in patients with advanced pancreatic cancer.

Keyphrases

circulating tumor